{
    "code": "02019767",
    "url": "http:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02019767",
    "time": "2016-11-18 19:44:02",
    "許可證字號": "衛署藥輸字第019767號",
    "註銷狀態": "已註銷",
    "註銷日期": "87\/10\/20",
    "註銷理由": "自請註銷",
    "有效日期": "87\/07\/24",
    "發證日期": "82\/02\/17",
    "許可證種類": "製　劑",
    "舊證字號": "02015083",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA00201976700",
    "中文品名": "甲基硫醇咪唑注射液",
    "英文品名": "MERCAZOLE (R) INJECTION",
    "適應症": "甲狀腺機能亢進",
    "劑型": "270注射劑",
    "包裝": "安瓿",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "05限由醫師使用",
    "主成分略述": [
        "METHIMAZOLE"
    ],
    "限制項目": "02輸　入",
    "申請商名稱": "0416001100  日商仲外製藥股份有限公司台北分公司",
    "主製造廠": {
        "主製造廠": "",
        "製造廠名稱": "F260026000  USV LIMITED",
        "製造廠廠址": "5-1, UKIMA 5-CHOME, KITA-KU, TOKYO1-9, KYOBASHI 2-CHOME CHUO-KU TLKYO",
        "製造廠公司地址": "1-9, KYOBASHI 2-CHOME CHUO-KU TLKYO",
        "": ""
    },
    "CCC號列": "",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "6836800300",
            "成分名稱": "METHIMAZOLE",
            "含量描述": "10",
            "含量": "10.0000000000",
            "單位": "MG"
        }
    ]
}